BusinessArch Biopartners Announces AB569 Phase I Human Trial Begins Patient Recruitment and Enrollment StageBy Nasdaq OMXFeb 13, 2018, 1:03 PM UTC
BusinessCeltaxsys Secures Private Financing to Advance Acebilustat Phase 3 Cystic Fibrosis (CF) Program Preparatory ActivitiesBy Nasdaq OMXJan 4, 2018, 1:02 PM UTC
